1. A phase II study of AT9283, an aurora kinase inhibitor, in patients with relapsed or refractory multiple myeloma: NCIC clinical trials group IND.191. Issue 6 (2nd June 2016) Authors: Hay, Annette E.; Murugesan, Alli; DiPasquale, Ashley M.; Kouroukis, Tom; Sandhu, Irwindeep; Kukreti, Vishal; Bahlis, Nizar J.; Lategan, Johan; Reece, Donna E.; Lyons, John F.; Sederias, Joana; Xu, Hao; Powers, Jean; Seymour, Lesley K.; Reiman, Tony Journal: Leukemia & lymphoma Issue: Volume 57:Issue 6(2016:Jun.) Page Start: 1463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022) Authors: Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar... Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial. Issue 8 (2nd August 2021) Authors: Döhner, Hartmut; Symeonidis, Argiris; Deeren, Dries; Demeter, Judit; Sanz, Miguel A.; Anagnostopoulos, Achilles; Esteve, Jordi; Fiedler, Walter; Porkka, Kimmo; Kim, Hee-Je; Lee, Je-Hwan; Usuki, Kensuke; D'Ardia, Stefano; Won Jung, Chul; Salamero, Olga; Horst, Heinz-August; Recher, Christian; Rous... Journal: HemaSphere Issue: Volume 5:Issue 8(2021) Page Start: e617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy. (17th August 2020) Authors: Benson, Matthew D.; Plemel, David J. A.; Yacyshyn, Elaine; Sandhu, Irwindeep; MacDonald, Ian M.; Baker, Chad F. Journal: Ocular immunology and inflammation Issue: Volume 28:Number 6(2020) Page Start: 958 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma. Issue 22 (1st August 2021) Authors: Richardson, Paul G.; Kumar, Shaji K.; Masszi, Tamás; Grzasko, Norbert; Bahlis, Nizar J.; Hansson, Markus; Pour, Luděk; Sandhu, Irwindeep; Ganly, Peter; Baker, Bartrum W.; Jackson, Sharon R.; Stoppa, Anne-Marie; Gimsing, Peter; Garderet, Laurent; Touzeau, Cyrille; Buadi, Francis K.; Laubach, Jacob... Journal: Journal of clinical oncology Issue: Volume 39:Issue 22(2021) Page Start: 2430 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Incremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid Leukemia. (June 2016) Authors: Saini, Lalit; Brandwein, Joseph; Turner, Robert; Larratt, Loree; Hamilton, Marlene; Peters, Anthea; Wu, Cynthia; Zhu, Nancy; Taparia, Minakshi; Patterson, Jeffery M.; Bolster, Lauren; Mant, Michael; Ritchie, Bruce; Liew, Elena; Mirza, Imran; Quest, Graeme; Nahirniak, Susan; Ghosh, Sunita; Sandhu,... Journal: Leukemia research Issue: Volume 45(2016:Jun.) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lenalidomide: from relapsed/refractory multiple myeloma to upfront therapy. (October 2011) Authors: Sandhu, Irwindeep; Belch, Andrew Journal: Aging health Issue: Volume 7:Number 5(2011) Page Start: 665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Persistent cytogenetic abnormalities in patients undergoing intensive chemotherapy for acute myeloid leukemia. Issue 1 (2nd January 2018) Authors: Saini, Lalit; Brandwein, Joseph; Szkotak, Artur; Ghosh, Sunita; Sandhu, Irwindeep Journal: Leukemia & lymphoma Issue: Volume 59:Issue 1(2018) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The fludarabine, cytarabine, and granulocyte colony‐stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline‐based therapy for the treatment of acute myeloid leukemia for patients with pre‐existing cardiac disease. (3rd May 2016) Authors: Saini, Lalit; Brandwein, Joseph; Turner, Robert; Larratt, Loree; Hamilton, Marlene; Peters, Anthea; Wu, Cynthia; Zhu, Nancy; Patterson, Jeffery M.; Bolster, Lauren; Mant, Michael; Ritchie, Bruce; Liew, Elena; Ghosh, Sunita; Sandhu, Irwindeep Journal: European journal of haematology Issue: Volume 97:Number 5(2016:Nov.) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN‐003/MYX.1 single arm phase II trial. Issue 5 (12th April 2021) Authors: Venner, Christopher P.; LeBlanc, Richard; Sandhu, Irwindeep; White, Darrell; Belch, Andrew R.; Reece, Donna E.; Chen, Christine; Dolan, Sean; Lalancette, Marc; Louzada, Martha; Kew, Andrea; McCurdy, Arleigh; Monteith, Bethany; Reiman, Tony; McDonald, Gail; Sherry, Max; Gul, Engin; Chen, Bingshu E... Journal: American journal of hematology Issue: Volume 96:Issue 5(2021) Page Start: 552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗